Related Experiment Video

Updated: Aug 5, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Short-term developmental outcome of iron prophylaxis in infants

S S Yalçin1, K Yurdakök, D Açikgöz

  • 1Department of Social Pediatrics, Institute of Child Health, Ankara, Turkey.

Pediatrics International : Official Journal of the Japan Pediatric Society
|February 24, 2001
PubMed

Insights

Short-term iron supplementation did not impact cognitive development in healthy, iron-sufficient infants. While iron levels improved, developmental scores remained normal, highlighting the importance of preventing iron deficiency anemia.

Area of Science:

  • Pediatric Nutrition
  • Developmental Pediatrics
  • Hematology

Background:

  • Cognitive effects of iron treatment primarily studied in anemic infants.
  • Limited research on iron supplementation in iron-sufficient infants.
  • Need to assess iron's impact on cognitive development in healthy, iron-sufficient infants.

Purpose of the Study:

  • Examine iron supplementation's effect on cognitive development using Bayley Scales of Infant Development (BSID).
  • Evaluate impact on anthropometric measurements in 6-month-old iron-sufficient infants.
  • Assess hematologic status changes over 3 months.

Main Methods:

  • Recruited healthy, iron-sufficient 6-month-old infants.
  • Randomly assigned infants to ferrous sulfate supplementation (1 mg/kg/day) or placebo.
  • Monitored anthropometrics, hematologic status, and BSID at baseline and 3 months.

Main Results:

  • No significant differences in anthropometrics or complete blood counts between groups.
  • Transferrin saturation (TS) decreased in the control group but remained stable in the supplemented group.
  • Significantly lower TS in the control group compared to the intervention group post-study; BSID scores remained within normal limits for both.

Conclusions:

  • Short-term iron supplementation did not alter cognitive test scores in iron-sufficient infants.
  • Hematologic response observed, but developmental outcomes were unaffected.
  • Emphasizes prevention of iron-deficiency anemia over treatment for optimal developmental outcomes.
Abstract

More Related Videos

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...